This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
This report contains market size and forecasts of CRISPR and CRISPR-Associated (Cas) Genes in Global, including the following market information:
Global CRISPR and CRISPR-Associated (Cas) Genes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CRISPR and CRISPR-Associated (Cas) Genes market was valued at 1424.5 million in 2021 and is projected to reach US$ 9195.8 million by 2028, at a CAGR of 30.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genome Editing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CRISPR and CRISPR-Associated (Cas) Genes include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich and Precision Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRISPR and CRISPR-Associated (Cas) Genes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR and CRISPR-Associated (Cas) Genes Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CRISPR and CRISPR-Associated (Cas) Genes Market Segment Percentages, by Type, 2021 (%)
- Genome Editing
- Genetic engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
Global CRISPR and CRISPR-Associated (Cas) Genes Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global CRISPR and CRISPR-Associated (Cas) Genes Market Segment Percentages, by Application, 2021 (%)
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
Global CRISPR and CRISPR-Associated (Cas) Genes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global CRISPR and CRISPR-Associated (Cas) Genes Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR and CRISPR-Associated (Cas) Genes revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CRISPR and CRISPR-Associated (Cas) Genes revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific
- Editas Medicine
- Caribou Biosciences
- CRISPR therapeutics
- Intellia therapeutics, Inc.
- Cellectis
- Horizon Discovery Plc
- Sigma Aldrich
- Precision Biosciences
- Genscript
- Sangamo Biosciences Inc.
- Lonza Group Limited
- Integrated DNA Technologies
- New England Biolabs
- Origene Technologies
CRISPR and CRISPR-Associated (Cas) Genes Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 CRISPR and CRISPR-Associated (Cas) Genes Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CRISPR and CRISPR-Associated (Cas) Genes Overall Market Size
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size: 2021 VS 2028
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CRISPR and CRISPR-Associated (Cas) Genes Players in Global Market
3.2 Top Global CRISPR and CRISPR-Associated (Cas) Genes Companies Ranked by Revenue
3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Companies
3.4 Top 3 and Top 5 CRISPR and CRISPR-Associated (Cas) Genes Companies in Global Market, by Revenue in 2021
3.5 Global Companies CRISPR and CRISPR-Associated (Cas) Genes Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRISPR and CRISPR-Associated (Cas) Genes Players in Global Market
3.6.1 List of Global Tier 1 CRISPR and CRISPR-Associated (Cas) Genes Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR and CRISPR-Associated (Cas) Genes Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Markets, 2021 & 2028
4.1.2 Genome Editing
4.1.3 Genetic engineering
4.1.4 gRNA Database/Gene Librar
4.1.5 CRISPR Plasmid
4.1.6 Human Stem Cells
4.1.7 Genetically Modified Organisms/Crops
4.1.8 Cell Line Engineering
4.2 By Type - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue & Forecasts
4.2.1 By Type - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2022
4.2.2 By Type - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2023-2028
4.2.3 By Type - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2021 & 2028
5.1.2 Biotechnology Companies
5.1.3 Pharmaceutical Companies
5.1.4 Academic Institutes
5.1.5 Research and Development Institutes
5.2 By Application - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue & Forecasts
5.2.1 By Application - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2022
5.2.2 By Application - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2023-2028
5.2.3 By Application - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2021 & 2028
6.2 By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue & Forecasts
6.2.1 By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2022
6.2.2 By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2023-2028
6.2.3 By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2028
6.3.2 US CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.3.3 Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.3.4 Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2028
6.4.2 Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.4.3 France CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.4.4 U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.4.5 Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.4.6 Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.4.7 Nordic Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.4.8 Benelux CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2028
6.5.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.5.3 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.5.4 South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.5.5 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.5.6 India CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2028
6.6.2 Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.6.3 Argentina CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2028
6.7.2 Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.7.3 Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.7.4 Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
6.7.5 UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size, 2017-2028
7 Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.1.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 Editas Medicine
7.2.1 Editas Medicine Corporate Summary
7.2.2 Editas Medicine Business Overview
7.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.2.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.2.5 Editas Medicine Key News
7.3 Caribou Biosciences
7.3.1 Caribou Biosciences Corporate Summary
7.3.2 Caribou Biosciences Business Overview
7.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.3.5 Caribou Biosciences Key News
7.4 CRISPR therapeutics
7.4.1 CRISPR therapeutics Corporate Summary
7.4.2 CRISPR therapeutics Business Overview
7.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.4.4 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.4.5 CRISPR therapeutics Key News
7.5 Intellia therapeutics, Inc.
7.5.1 Intellia therapeutics, Inc. Corporate Summary
7.5.2 Intellia therapeutics, Inc. Business Overview
7.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.5.4 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.5.5 Intellia therapeutics, Inc. Key News
7.6 Cellectis
7.6.1 Cellectis Corporate Summary
7.6.2 Cellectis Business Overview
7.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.6.4 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.6.5 Cellectis Key News
7.7 Horizon Discovery Plc
7.7.1 Horizon Discovery Plc Corporate Summary
7.7.2 Horizon Discovery Plc Business Overview
7.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.7.4 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.7.5 Horizon Discovery Plc Key News
7.8 Sigma Aldrich
7.8.1 Sigma Aldrich Corporate Summary
7.8.2 Sigma Aldrich Business Overview
7.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.8.4 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.8.5 Sigma Aldrich Key News
7.9 Precision Biosciences
7.9.1 Precision Biosciences Corporate Summary
7.9.2 Precision Biosciences Business Overview
7.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.9.4 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.9.5 Precision Biosciences Key News
7.10 Genscript
7.10.1 Genscript Corporate Summary
7.10.2 Genscript Business Overview
7.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.10.4 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.10.5 Genscript Key News
7.11 Sangamo Biosciences Inc.
7.11.1 Sangamo Biosciences Inc. Corporate Summary
7.11.2 Sangamo Biosciences Inc. Business Overview
7.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.11.4 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.11.5 Sangamo Biosciences Inc. Key News
7.12 Lonza Group Limited
7.12.1 Lonza Group Limited Corporate Summary
7.12.2 Lonza Group Limited Business Overview
7.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.12.4 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.12.5 Lonza Group Limited Key News
7.13 Integrated DNA Technologies
7.13.1 Integrated DNA Technologies Corporate Summary
7.13.2 Integrated DNA Technologies Business Overview
7.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.13.4 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.13.5 Integrated DNA Technologies Key News
7.14 New England Biolabs
7.14.1 New England Biolabs Corporate Summary
7.14.2 New England Biolabs Business Overview
7.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.14.4 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.14.5 New England Biolabs Key News
7.15 Origene Technologies
7.15.1 Origene Technologies Corporate Summary
7.15.2 Origene Technologies Business Overview
7.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Major Product Offerings
7.15.4 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global Market (2017-2022)
7.15.5 Origene Technologies Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. CRISPR and CRISPR-Associated (Cas) Genes Market Opportunities & Trends in Global Market
Table 2. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers in Global Market
Table 3. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints in Global Market
Table 4. Key Players of CRISPR and CRISPR-Associated (Cas) Genes in Global Market
Table 5. Top CRISPR and CRISPR-Associated (Cas) Genes Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Companies, 2017-2022
Table 8. Global Companies CRISPR and CRISPR-Associated (Cas) Genes Product Type
Table 9. List of Global Tier 1 CRISPR and CRISPR-Associated (Cas) Genes Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CRISPR and CRISPR-Associated (Cas) Genes Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CRISPR and CRISPR-Associated (Cas) Genes Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 32. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 33. Editas Medicine Corporate Summary
Table 34. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 35. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 36. Caribou Biosciences Corporate Summary
Table 37. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 38. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 39. CRISPR therapeutics Corporate Summary
Table 40. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 41. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 42. Intellia therapeutics, Inc. Corporate Summary
Table 43. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 44. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 45. Cellectis Corporate Summary
Table 46. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 47. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 48. Horizon Discovery Plc Corporate Summary
Table 49. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 50. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 51. Sigma Aldrich Corporate Summary
Table 52. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 53. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 54. Precision Biosciences Corporate Summary
Table 55. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 56. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 57. Genscript Corporate Summary
Table 58. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 59. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 60. Sangamo Biosciences Inc. Corporate Summary
Table 61. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 62. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 63. Lonza Group Limited Corporate Summary
Table 64. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 65. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 66. Integrated DNA Technologies Corporate Summary
Table 67. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 68. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 69. New England Biolabs Corporate Summary
Table 70. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 71. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
Table 72. Origene Technologies Corporate Summary
Table 73. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offerings
Table 74. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Segment by Type in 2021
Figure 2. CRISPR and CRISPR-Associated (Cas) Genes Segment by Application in 2021
Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
Figure 8. By Type - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
Figure 9. By Application - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
Figure 10. By Region - Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
Figure 11. By Country - North America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
Figure 12. US CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
Figure 16. Germany CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 17. France CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
Figure 24. China CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 28. India CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
Figure 30. Brazil CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share, 2017-2028
Figure 33. Turkey CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 149
According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period.
The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period.
The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 154
According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period.
The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 125
According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period.
The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 120
Market Overview of Global Polymerase Chain Reaction (Pcr) Products market:
According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents......
Next Generation Sequencing - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 102
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 124
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
Global Genotyping Market Status and Outlook 2023-2028
Published: 26-Dec-2023 Price: US 3160 Onwards Pages: 128
Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 101
Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
